Stocks · Health care · Biological Products, (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC.

RXRX Clue Score60
United States Fiscal year ends December CIK 0001601830 Results filed 2 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Blake Borgeson
3 Nov 2026
Director
Sold on a plan
40,000
$3.88
$155.20K
Blake Borgeson
6 Oct 2026
Director
Sold on a plan
50,000
$4.84
$242.00K
Najat Khan
8 Sep 2026
CEO and President
Sold on a plan
22,408
$3.52
$78.82K
Blake Borgeson
1 Sep 2026
Director
Sold on a plan
30,000
$3.34
$100.20K
Blake Borgeson
4 Aug 2026
Director
Sold on a plan
30,000
$3.25
$97.50K
Blake Borgeson
7 Jul 2026
Director
Sold on a plan
40,000
$3.96
$158.50K
Namandje Bumpus
18 Jun 2026
Director
Sold on a plan
3,963
$3.18
$12.60K
Najat Khan
5 Jun 2026
CEO and President
Sold on a plan
23,588
$3.58
$84.46K
Namandje Bumpus
3 Jun 2026
Director
Sold on a plan
4,386
$3.54
$15.53K
Blake Borgeson
2 Jun 2026
Director
Sold on a plan
30,000
$3.68
$110.40K
Blake Borgeson
5 May 2026
Director
Sold on a plan
30,000
$3.52
$105.60K
Blake Borgeson
7 Apr 2026
Director
Sold on a plan
30,000
$3.10
$93.00K
Ben R Taylor
17 Mar 2026
Chief Financial Officer
Sold on a plan
7,956
$3.39
$26.97K
Najat Khan
9 Mar 2026
CEO and President
Sold on a plan
28,298
$3.35
$94.66K
Blake Borgeson
3 Mar 2026
Director
Sold on a plan
170,000
$3.46
$588.20K
Ben R Taylor
18 Feb 2026
Chief Financial Officer
Sold on a plan
13,426
$3.08
$41.35K
Blake Borgeson
3 Feb 2026
Director
Sold on a plan
220,000
$4.20
$924.00K
Blake Borgeson
6 Jan 2026
Director
Sold on a plan
220,000
$4.36
$959.20K
Ben R Taylor
29 Dec 2025
Chief Financial Officer
Sold on a plan
21,383
$4.18
$89.38K
Najat Khan
22 Dec 2025
Chief R&D Commercial Officer
Sold on a plan
124,403
$4.41
$548.59K
Blake Borgeson
2 Dec 2025
Director
Sold on a plan
220,000
$4.37
$961.40K
Christopher Gibson
27 Mar 2025
Chief Executive Officer
Sold on a plan
138,574
$6.04
$836.99K
Blake Borgeson
12 Nov 2024
Director
Sold on a plan
11,447
$7.64
$87.46K
Blake Borgeson
29 Oct 2024
Director
Sold on a plan
11,447
$6.72
$76.93K
Blake Borgeson
15 Oct 2024
Director
Sold on a plan
11,447
$6.67
$76.33K
Blake Borgeson
1 Oct 2024
Director
Sold on a plan
11,447
$6.22
$71.15K
Blake Borgeson
17 Sep 2024
Director
Sold on a plan
11,447
$6.84
$78.33K
Blake Borgeson
3 Sep 2024
Director
Sold on a plan
11,447
$6.27
$71.72K
Blake Borgeson
20 Aug 2024
Director
Sold on a plan
11,447
$7.12
$81.53K
Blake Borgeson
6 Aug 2024
Director
Sold on a plan
11,447
$6.82
$78.08K
Blake Borgeson
23 Jul 2024
Director
Sold on a plan
11,447
$8.48
$97.04K
Blake Borgeson
9 Jul 2024
Director
Sold on a plan
11,447
$7.32
$83.73K
Blake Borgeson
25 Jun 2024
Director
Sold on a plan
11,447
$9.51
$108.81K
Blake Borgeson
11 Jun 2024
Director
Sold on a plan
11,447
$8.45
$96.76K
Christopher Gibson
6 Jun 2024
Chief Executive Officer
Sold on a plan
50,000
$9.00
$450.00K
Blake Borgeson
28 May 2024
Director
Sold on a plan
11,447
$9.17
$104.94K
Blake Borgeson
14 May 2024
Director
Sold on a plan
20,054
$10.12
$202.93K
Christopher Gibson
1 May 2024
Chief Executive Officer
Sold on a plan
50,000
$7.73
$386.50K
Blake Borgeson
30 Apr 2024
Director
Sold on a plan
11,447
$7.95
$90.96K
Blake Borgeson
16 Apr 2024
Director
Sold on a plan
11,447
$7.66
$87.73K
Blake Borgeson
2 Apr 2024
Director
Sold on a plan
11,447
$8.82
$100.94K
Blake Borgeson
19 Mar 2024
Director
Sold on a plan
20,054
$10.79
$216.42K
Blake Borgeson
5 Mar 2024
Director
Sold on a plan
20,054
$12.06
$241.81K
Blake Borgeson
20 Feb 2024
Director
Sold on a plan
309
$13.04
$4.03K
Blake Borgeson
20 Feb 2024
Director
Sold on a plan
19,745
$12.31
$243.09K
Blake Borgeson
6 Feb 2024
Director
Sold on a plan
11,447
$9.30
$106.49K
Blake Borgeson
23 Jan 2024
Director
Sold on a plan
20,054
$10.58
$212.08K
Blake Borgeson
9 Jan 2024
Director
Sold on a plan
13,751
$13.81
$189.92K
Blake Borgeson
9 Jan 2024
Director
Sold on a plan
6,303
$13.21
$83.28K
Dean Y Li
9 Jan 2024
Director
Sold on a plan indirect
962
$14.03
$13.50K
Dean Y Li
9 Jan 2024
Director
Sold on a plan indirect
28,038
$13.65
$382.72K
Blake Borgeson
26 Dec 2023
Director
Sold on a plan
20,054
$10.63
$213.14K
Zavain Dar
14 Dec 2023
Director
Sold on a plan
20,141
$9.00
$181.27K
Blake Borgeson
12 Dec 2023
Director
Sold on a plan
11,447
$7.40
$84.69K
Blake Borgeson
28 Nov 2023
Director
Sold on a plan
11,447
$6.72
$76.92K
Shafique Virani
2 Jun 2023
Chief Business Officer
Sold on a plan
17,865
$8.93
$159.53K
Shafique Virani
1 Jun 2023
Chief Business Officer
Sold on a plan
25,000
$8.58
$214.50K
Showing 250 of 464 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 479
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 57
Sales straight out of an exercise 308
Sales at will 56
Transactions with no price 0
Shares from compensation/vesting 217,995,789
Sales filed before the plan box existed 31
History held since 19 Apr 2021